News & Blog
News & Blog
2025 rideATAXIA Gainesville Recap
Press Release & Community Update: Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study
Meet the Community: Natalija Stanojevic
Meet the Community: Tyler and Amanda
March 2025 – Advocacy Newsletter
Meet the Community: Julie Haffner
Press Release & Community Update: Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Meet the Community: Sam Dupre
SKYCLARYS™ (omaveloxolone) Approval by Health Canada Ushers in a New Era for Friedreich’s Ataxia Treatment in Canada
